Lam T, Hayman J, Berecki-Gisolf J, Sanfilippo P, Lubman DI, Nielsen S. Pharmaceutical opioid poisonings in Victoria, Australia: rates and characteristics of a decade of Emergency Department presentations across nine pharmaceutical opioids [published online ahead of print, 2021 Aug 2]. Addiction. 2021;10.1111/add.15653. doi:10.1111/add.15653

Green JL, Robbins RS, Dailey-Govoni T, Butler SF. Nonmedical Use of Xtampza® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV®). J Pain Res. 2021;14:1773-1783. Published 2021 Jun 15. doi:10.2147/JPR.S304805

Vosburg SK, Beaumont J, Dailey-Govoni ST, Butler SF, Green JL. Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index-Multimedia Version (ASI-MV). Pain Med. 2020;21(9):1891-1901. doi:10.1093/pm/pnz250